Concepedia

Diphtheria Toxin–Epidermal Growth Factor Fusion Protein DAB389EGF for the Treatment of Bladder Cancer

Xiaoping Yang, Elizabeth R. Kessler, Lih-Jen Su, Andrew Thorburn, Arthur E. Frankel, Yuan Li, Francisco G. La Rosa, Jingping Shen, Chuan-Yuan Li, Marileila Varella‐Garcia,

Clinical Cancer Research · 2012 · 46 citations · 18 references

DOIFull text

Open access

Abstract

The intravesical delivery of targeted toxin fusion proteins is a novel treatment approach for non-muscle-invasive urinary bladder cancer. With appropriate targeting, the treatments are effective and well-tolerated in vivo.

References

18

Cancer statistics, 2011

Rebecca L. Siegel, Elizabeth Ward, Otis W. Brawley et al. · CA A Cancer Journal for Clinicians · 2011 · 4.1K citations · Full text

, , +19

Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Wei Wang, Qi Li, Tadaaki Yamada et al. · Clinical Cancer Research · 2009 · 295 citations

Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.

N.‐H. Chow, S. H. Chan, T. S. Tzai et al. · PubMed · 2001 · 243 citations

, , +17

Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients With Cutaneous T-Cell Lymphoma

H. Miles Prince, Madeleine Duvic, Ann Martin et al. · Journal of Clinical Oncology · 2010 · 231 citations

, , +17

Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.

Edward M. Messing · PubMed · 1990 · 182 citations

, , +16